Consensus study on the health system and patient-related barriers for lung cancer management in South Africa.
Witness MapangaShane A NorrisWenlong Carl ChenCharmaine L BlanchardAnita GrahamLaurel Baldwin-RagavenTom BoylesBernard DondeLinda GreefKen HuddleBusisiwe KhumaloElizabeth LeepileBuhle LubuzoRaynolda MakhutleYusuf MayetMerika TsitsiPreethi MistriKeletso MmolediMpho Ratshikana-MolokoRajen MorerLauren PretoriusJayshina PunwasiGuy A RichardsPaul RuffDineo ShabalalaMaureen SibadelaNita SomaMichelle WongMaureen JoffePublished in: PloS one (2021)
Considerable barriers to the early identification and treatment of lung cancer exist. Finding solutions to overcome both individual and health-system level obstacles to lung cancer screening and management are vital to facilitate early identification and treatment, and to improve survival. Furthermore, research on inexpensive biomarkers for asymptomatic disease detection, the introduction of diagnostic imaging tools that utilise artificial intelligence to compensate for inadequate human resources and improving clinical integration across all levels of the healthcare system are essential.